LAB - LAB VINO and BROG are among pre market gainers
2023-10-04 08:13:40 ET
- Gainers: Freeline Therapeutics ( FRLN ) +51% Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease.
- Gaucho Group ( VINO ) +22% .
- Brooge Energy ( BROG ) +13% receives takeover proposal from Gulfnav; no details provided.
- Standard BioTools ( LAB ) +11% SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools.
- FREYR Battery ( FREY ) +6% Provides Operations Update.
For further details see:
LAB, VINO and BROG are among pre market gainers